Work

A phase I trial of trimetrexate (NSC352122) on a daily × 5 schedule in patients with refractory adult leukemia

Year: 1993

Type: article

Study design: Clinical Trial

Source: Anti-Cancer Drugs

DOI: 10.1097/00001813-199304000-00005

Authors: Gladys Rodriguez, Thomas D Brown, Frank M Balis, John B Craig, Claude A Denham, John G Kuhn, Kathleen Havlin, Daniel D Von Hoff

Institutions: The University of Texas at San Antonio Health Science Center, Duke Medical Center, National Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: GENERAL CLINICAL RESEARCH CENTER, G4744090504, PHASE I AND CLINICAL PHARMACOKINETIC STUDIES OF ANTI-, G8732274046

OpenAlex ID: W2069507330

FWCI: 0.227

Cites:

Cited by: 3

Related to: 10